Exogenous HIV-1 Vpr disrupts IFN-α response by plasmacytoid dendritic cells (pDCs) and subsequent pDC/NK interplay

Immunology Letters

Volumn 125, Issue 2, 2009, Pages 100-104

  Hong, Henoch Sangjoon ^a   Bhatnagar, Nupur ^a   Ballmaier, Matthias ^a   Schubert, Ulrich ^b   Henklein, Peter ^c   Volgmann, Thorsten ^d   Heiken, Hans ^a   Schmidt, Reinhold E ^a   Meyer Olson, Dirk ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

^d DRK Blutspendedienst NSTOB   (Germany)

Author keywords

HIV; NK cells; Plasmocytoid dendritic cells

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; VPR PROTEIN;

APOPTOSIS; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOMODULATION; INNATE IMMUNITY; NATURAL KILLER CELL; PRIORITY JOURNAL; VIRUS PATHOGENESIS;

CELLS, CULTURED; DENDRITIC CELLS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-ALPHA; INTERFERON-GAMMA; KILLER CELLS, NATURAL; PARACRINE COMMUNICATION; VPR GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 68149137723     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2009.06.008     Document Type: Article

References (28)

1. Lanier L.L. Evolutionary struggles between NK cells and viruses. Nat Rev Immunol 8 (2008) 259-268
2. Fauci A.S., Mavilio D., and Kottilil S. NK cells in HIV infection: paradigm for protection or targets for ambush. Nat Rev Immunol 5 (2005) 835-843
3. Lanier L.L. NK cell recognition. Annu Rev Immunol 23 (2005) 225-274
4. Gerosa F., Gobbi A., Zorzi P., Burg S., Briere F., Carra G., and Trinchieri G. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J Immunol 174 (2005) 727-734
5. Moretta A., Marcenaro E., Sivori S., Della Chiesa M., Vitale M., and Moretta L. Early liaisons between cells of the innate immune system in inflamed peripheral tissues. Trends Immunol 26 (2005) 668-675
6. Hanabuchi S., Watanabe N., Wang Y.H., Wang Y.H., Ito T., Shaw J., Cao W., Qin F.X., and Liu Y.J. Human plasmacytoid predendritic cells activate NK cells through glucocorticoid-induced tumor necrosis factor receptor-ligand (GITRL). Blood 107 (2006) 3617-3623
7. Romagnani C., Della Chiesa M., Kohler S., Moewes B., Radbruch A., Moretta L., Moretta A., and Thiel A. Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4+ T helper cells and CD4+ CD25hi T regulatory cells. Eur J Immunol 35 (2005) 2452-2458
8. Tomescu C., Chehimi J., Maino V.C., and Montaner L.J. NK cell lysis of HIV-1-infected autologous CD4 primary T cells: requirement for IFN-mediated NK activation by plasmacytoid dendritic cells. J Immunol 179 (2007) 2097-2104
9. Gilliet M., Cao W., and Liu Y.J. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 8 (2008) 594-606
10. Donaghy H., Stebbing J., and Patterson S. Antigen presentation and the role of dendritic cells in HIV. Curr Opin Infect Dis 17 (2004) 1-6
11. Alter G., Teigen N., Davis B.T., Addo M.M., Suscovich T.J., Waring M.T., Streeck H., Johnston M.N., Staller K.D., Zaman M.T., Yu X.G., Lichterfeld M., Basgoz N., Rosenberg E.S., and Altfeld M. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood 106 (2005) 3366-3369
12. Smed-Sorensen A., Lore K., Vasudevan J., Louder M.K., Andersson J., Mascola J.R., Spetz A.L., and Koup R.A. Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells. J Virol 79 (2005) 8861-8869
13. Mavilio D., Benjamin J., Daucher M., Lombardo G., Kottilil S., Planta M.A., Marcenaro E., Bottino C., Moretta L., Moretta A., and Fauci A.S. Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proc Natl Acad Sci USA 100 (2003) 15011-15016
14. Muthumani K., Choo A.Y., Zong W.X., Madesh M., Hwang D.S., Premkumar A., Thieu K.P., Emmanuel J., Kumar S., Thompson C.B., and Weiner D.B. The HIV-1 Vpr and glucocorticoid receptor complex is a gain-of-function interaction that prevents the nuclear localization of PARP-1. Nat Cell Biol 8 (2006) 170-179
15. Ayyavoo V., Muthumani K., Kudchodkar S., Zhang D., Ramanathan P., Dayes N.S., Kim J.J., Sin J.I., Montaner L.J., and Weiner D.B. HIV-1 viral protein R compromises cellular immune function in vivo. Int Immunol 14 (2002) 13-22
16. Muthumani K., Desai B.M., Hwang D.S., Choo A.Y., Laddy D.J., Thieu K.P., Rao R.G., and Weiner D.B. HIV-1 Vpr and anti-inflammatory activity. DNA Cell Biol 23 (2004) 239-247
17. Hoshino S., Sun B., Konishi M., Shimura M., Segawa T., Hagiwara Y., Koyanagi Y., Iwamoto A., Mimaya J., Terunuma H., Kano S., and Ishizaka Y. Vpr in plasma of HIV type 1-positive patients is correlated with the HIV type 1 RNA titers. AIDS Res Hum Retroviruses 23 (2007) 391-397
18. Henklein P., Bruns K., Sherman M.P., Tessmer U., Licha K., Kopp J., de Noronha C.M., Greene W.C., Wray V., and Schubert U. Functional and structural characterization of synthetic HIV-1 Vpr that transduces cells, localizes to the nucleus, and induces G2 cell cycle arrest. J Biol Chem 275 (2000) 32016-32026
19. Muthumani K., Hwang D.S., Choo A.Y., Mayilvahanan S., Dayes N.S., Thieu K.P., and Weiner D.B. HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitro. Int Immunol 17 (2005) 103-116
20. Majumder B., Venkatachari N.J., O'Leary S., and Ayyavoo V. Infection with Vpr-positive human immunodeficiency virus type 1 impairs NK cell function indirectly through cytokine dysregulation of infected target cells. J Virol 82 (2008) 7189-7200
21. Fossen T., Wray V., Bruns K., Rachmat J., Henklein P., Tessmer U., Maczurek A., Klinger P., and Schubert U. Solution structure of the human immunodeficiency virus type 1 p6 protein. J Biol Chem 280 (2005) 42515-42527
22. Alter G., Malenfant J.M., and Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 294 (2004) 15-22
23. Wilk E., Korten S., Zielinska-Skowronek M., Schmidt R.E., and Meyer-Olson D. Modulation of Ly49 D expression after allogeneic bone marrow transplantation and functional consequences. Immunobiology 205 (2002) 267-281
24. Ayyavoo V., Mahboubi A., Mahalingam S., Ramalingam R., Kudchodkar S., Williams W.V., Green D.R., and Weiner D.B. HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B. Nat Med 3 (1997) 1117-1123
25. Stewart S.A., Poon B., Song J.Y., and Chen I.S. Human immunodeficiency virus type 1 vpr induces apoptosis through caspase activation. J Virol 74 (2000) 3105-3111
26. Kottilil S., Chun T.W., Moir S., Liu S., McLaughlin M., Hallahan C.W., Maldarelli F., Corey L., and Fauci A.S. Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function. J Infect Dis 187 (2003) 1038-1045
27. Ward J., and Barker E. Role of natural killer cells in HIV pathogenesis. Curr HIV/AIDS Rep 5 (2008) 44-50
28. Platanias L.C. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5 (2005) 375-386